Plasmavigilance—Adverse events among US Source plasma donors
Background Source plasma (SP) is the primary starting material for 87% of plasma‐derived medicinal products globally. Plasmavigilance is a program designed to collect, analyze, and monitor donor adverse events (AEs) across the SP collection industry. Donor retention depends on donors having a safe a...
Gespeichert in:
| Veröffentlicht in: | Transfusion (Philadelphia, Pa.) Pa.), 2021-10, Vol.61 (10), p.2941-2957 |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 2957 |
|---|---|
| container_issue | 10 |
| container_start_page | 2941 |
| container_title | Transfusion (Philadelphia, Pa.) |
| container_volume | 61 |
| creator | Schreiber, George B. Becker, Mark Fransen, Michelle Hershman, Janet Lenart, James Song, Guang Simon, Toby |
| description | Background
Source plasma (SP) is the primary starting material for 87% of plasma‐derived medicinal products globally. Plasmavigilance is a program designed to collect, analyze, and monitor donor adverse events (AEs) across the SP collection industry. Donor retention depends on donors having a safe and satisfactory experience. This study analyzes AE rates and SP donor characteristics that may be predictors of an AE.
Study Design and Methods
Donation data for 1.1 million donors making 12,183,182 SP donations over a 4‐month period were analyzed. This represented approximately 72% of the donations collected by the U.S. plasma industry. The Standard for Recording Donor Adverse Events was used for AE definitions and classifications.
Results
The overall AE rate was 15.85/104 donations. The two AEs with the highest rates were Hypotensive and Phlebotomy events (8.32 and 5.91/104 donations, respectively). Females had higher overall AE rates than males (25.76 vs. 9.85/104 donations), and first‐time donors had higher overall AE rates than repeat donors (136.66 vs. 12.37/104 donations). Weight, body mass index, age, and pre‐donation estimated blood volume also were predictors of AE.
Discussion
SP donors have low AE rates with 90% being events classified as Hypotensive or Phlebotomy. Special attention and mitigation strategies should be directed to donors who are young, lightweight (between 100 and 124 pounds), female, or first‐time donors to further reduce the incidence of AE, continue to ensure the donor has a safe experience, and facilitate donor retention.
See editorial on page 2803–2805, in this issue |
| doi_str_mv | 10.1111/trf.16612 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9291118</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2578689000</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4202-14df986bf583c65c3922975792bf3359f8630517f6c0bccd3bd021bfef34d1f13</originalsourceid><addsrcrecordid>eNp1kU1OwzAQhS0EouVnwQ0isYFFWv8kTrypVFUUkCqBaLu2HMcuqZK42E1RdxyCE3IS3KZCAonZzGK-eZo3D4ArBHvIV39tdQ9RivAR6KKYJCFmLD4GXQgjFCJEcAecObeEEGIG0SnokIgwiGnSBYPnUrhKbIpFUYpaqq-Pz2G-UdapQG1UvXaBqEy9CObTYGoaK1Ww2i8EuamNdRfgRIvSqctDPwfz8d1s9BBOnu4fR8NJKCMMcYiiXLOUZjpOiaSxJAxjlsQJw5kmJGY6pQTGKNFUwkzKnGQ5xCjTSpMoRxqRczBodVdNVqlc-susKPnKFpWwW25EwX9P6uKVL8yGM8z8h1IvcHMQsOatUW7Nq8JJVXrTyjSO45iiiGGCd-j1H3TpndfenqeSlKbMP9JTty0lrXHOKv1zDIJ8lwr3qfB9Kp7tt-x7Uart_yCfvYzbjW8gso1S</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2578689000</pqid></control><display><type>article</type><title>Plasmavigilance—Adverse events among US Source plasma donors</title><source>Wiley Online Library Journals Frontfile Complete</source><creator>Schreiber, George B. ; Becker, Mark ; Fransen, Michelle ; Hershman, Janet ; Lenart, James ; Song, Guang ; Simon, Toby</creator><creatorcontrib>Schreiber, George B. ; Becker, Mark ; Fransen, Michelle ; Hershman, Janet ; Lenart, James ; Song, Guang ; Simon, Toby</creatorcontrib><description>Background
Source plasma (SP) is the primary starting material for 87% of plasma‐derived medicinal products globally. Plasmavigilance is a program designed to collect, analyze, and monitor donor adverse events (AEs) across the SP collection industry. Donor retention depends on donors having a safe and satisfactory experience. This study analyzes AE rates and SP donor characteristics that may be predictors of an AE.
Study Design and Methods
Donation data for 1.1 million donors making 12,183,182 SP donations over a 4‐month period were analyzed. This represented approximately 72% of the donations collected by the U.S. plasma industry. The Standard for Recording Donor Adverse Events was used for AE definitions and classifications.
Results
The overall AE rate was 15.85/104 donations. The two AEs with the highest rates were Hypotensive and Phlebotomy events (8.32 and 5.91/104 donations, respectively). Females had higher overall AE rates than males (25.76 vs. 9.85/104 donations), and first‐time donors had higher overall AE rates than repeat donors (136.66 vs. 12.37/104 donations). Weight, body mass index, age, and pre‐donation estimated blood volume also were predictors of AE.
Discussion
SP donors have low AE rates with 90% being events classified as Hypotensive or Phlebotomy. Special attention and mitigation strategies should be directed to donors who are young, lightweight (between 100 and 124 pounds), female, or first‐time donors to further reduce the incidence of AE, continue to ensure the donor has a safe experience, and facilitate donor retention.
See editorial on page 2803–2805, in this issue</description><identifier>ISSN: 0041-1132</identifier><identifier>EISSN: 1537-2995</identifier><identifier>DOI: 10.1111/trf.16612</identifier><identifier>PMID: 34390267</identifier><language>eng</language><publisher>Hoboken, USA: John Wiley & Sons, Inc</publisher><subject>adverse events ; Blood Donors and Blood Collection ; Blood volume ; Body mass ; Body mass index ; Body size ; donation frequency ; Phlebotomy ; Plasma ; plasmavigilance ; Retention ; source plasma</subject><ispartof>Transfusion (Philadelphia, Pa.), 2021-10, Vol.61 (10), p.2941-2957</ispartof><rights>2021 Plasma Protein Therapeutics Association. published by Wiley Periodicals LLC on behalf of AABB.</rights><rights>2021. This article is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4202-14df986bf583c65c3922975792bf3359f8630517f6c0bccd3bd021bfef34d1f13</citedby><cites>FETCH-LOGICAL-c4202-14df986bf583c65c3922975792bf3359f8630517f6c0bccd3bd021bfef34d1f13</cites><orcidid>0000-0003-1602-5248</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Ftrf.16612$$EPDF$$P50$$Gwiley$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Ftrf.16612$$EHTML$$P50$$Gwiley$$Hfree_for_read</linktohtml><link.rule.ids>230,314,780,784,885,1416,27922,27923,45572,45573</link.rule.ids></links><search><creatorcontrib>Schreiber, George B.</creatorcontrib><creatorcontrib>Becker, Mark</creatorcontrib><creatorcontrib>Fransen, Michelle</creatorcontrib><creatorcontrib>Hershman, Janet</creatorcontrib><creatorcontrib>Lenart, James</creatorcontrib><creatorcontrib>Song, Guang</creatorcontrib><creatorcontrib>Simon, Toby</creatorcontrib><title>Plasmavigilance—Adverse events among US Source plasma donors</title><title>Transfusion (Philadelphia, Pa.)</title><description>Background
Source plasma (SP) is the primary starting material for 87% of plasma‐derived medicinal products globally. Plasmavigilance is a program designed to collect, analyze, and monitor donor adverse events (AEs) across the SP collection industry. Donor retention depends on donors having a safe and satisfactory experience. This study analyzes AE rates and SP donor characteristics that may be predictors of an AE.
Study Design and Methods
Donation data for 1.1 million donors making 12,183,182 SP donations over a 4‐month period were analyzed. This represented approximately 72% of the donations collected by the U.S. plasma industry. The Standard for Recording Donor Adverse Events was used for AE definitions and classifications.
Results
The overall AE rate was 15.85/104 donations. The two AEs with the highest rates were Hypotensive and Phlebotomy events (8.32 and 5.91/104 donations, respectively). Females had higher overall AE rates than males (25.76 vs. 9.85/104 donations), and first‐time donors had higher overall AE rates than repeat donors (136.66 vs. 12.37/104 donations). Weight, body mass index, age, and pre‐donation estimated blood volume also were predictors of AE.
Discussion
SP donors have low AE rates with 90% being events classified as Hypotensive or Phlebotomy. Special attention and mitigation strategies should be directed to donors who are young, lightweight (between 100 and 124 pounds), female, or first‐time donors to further reduce the incidence of AE, continue to ensure the donor has a safe experience, and facilitate donor retention.
See editorial on page 2803–2805, in this issue</description><subject>adverse events</subject><subject>Blood Donors and Blood Collection</subject><subject>Blood volume</subject><subject>Body mass</subject><subject>Body mass index</subject><subject>Body size</subject><subject>donation frequency</subject><subject>Phlebotomy</subject><subject>Plasma</subject><subject>plasmavigilance</subject><subject>Retention</subject><subject>source plasma</subject><issn>0041-1132</issn><issn>1537-2995</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><sourceid>WIN</sourceid><recordid>eNp1kU1OwzAQhS0EouVnwQ0isYFFWv8kTrypVFUUkCqBaLu2HMcuqZK42E1RdxyCE3IS3KZCAonZzGK-eZo3D4ArBHvIV39tdQ9RivAR6KKYJCFmLD4GXQgjFCJEcAecObeEEGIG0SnokIgwiGnSBYPnUrhKbIpFUYpaqq-Pz2G-UdapQG1UvXaBqEy9CObTYGoaK1Ww2i8EuamNdRfgRIvSqctDPwfz8d1s9BBOnu4fR8NJKCMMcYiiXLOUZjpOiaSxJAxjlsQJw5kmJGY6pQTGKNFUwkzKnGQ5xCjTSpMoRxqRczBodVdNVqlc-susKPnKFpWwW25EwX9P6uKVL8yGM8z8h1IvcHMQsOatUW7Nq8JJVXrTyjSO45iiiGGCd-j1H3TpndfenqeSlKbMP9JTty0lrXHOKv1zDIJ8lwr3qfB9Kp7tt-x7Uart_yCfvYzbjW8gso1S</recordid><startdate>202110</startdate><enddate>202110</enddate><creator>Schreiber, George B.</creator><creator>Becker, Mark</creator><creator>Fransen, Michelle</creator><creator>Hershman, Janet</creator><creator>Lenart, James</creator><creator>Song, Guang</creator><creator>Simon, Toby</creator><general>John Wiley & Sons, Inc</general><general>Wiley Subscription Services, Inc</general><scope>24P</scope><scope>WIN</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>7U9</scope><scope>8FD</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>P64</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-1602-5248</orcidid></search><sort><creationdate>202110</creationdate><title>Plasmavigilance—Adverse events among US Source plasma donors</title><author>Schreiber, George B. ; Becker, Mark ; Fransen, Michelle ; Hershman, Janet ; Lenart, James ; Song, Guang ; Simon, Toby</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4202-14df986bf583c65c3922975792bf3359f8630517f6c0bccd3bd021bfef34d1f13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>adverse events</topic><topic>Blood Donors and Blood Collection</topic><topic>Blood volume</topic><topic>Body mass</topic><topic>Body mass index</topic><topic>Body size</topic><topic>donation frequency</topic><topic>Phlebotomy</topic><topic>Plasma</topic><topic>plasmavigilance</topic><topic>Retention</topic><topic>source plasma</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Schreiber, George B.</creatorcontrib><creatorcontrib>Becker, Mark</creatorcontrib><creatorcontrib>Fransen, Michelle</creatorcontrib><creatorcontrib>Hershman, Janet</creatorcontrib><creatorcontrib>Lenart, James</creatorcontrib><creatorcontrib>Song, Guang</creatorcontrib><creatorcontrib>Simon, Toby</creatorcontrib><collection>Wiley Online Library Open Access</collection><collection>Wiley Online Library Free Content</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Transfusion (Philadelphia, Pa.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Schreiber, George B.</au><au>Becker, Mark</au><au>Fransen, Michelle</au><au>Hershman, Janet</au><au>Lenart, James</au><au>Song, Guang</au><au>Simon, Toby</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Plasmavigilance—Adverse events among US Source plasma donors</atitle><jtitle>Transfusion (Philadelphia, Pa.)</jtitle><date>2021-10</date><risdate>2021</risdate><volume>61</volume><issue>10</issue><spage>2941</spage><epage>2957</epage><pages>2941-2957</pages><issn>0041-1132</issn><eissn>1537-2995</eissn><abstract>Background
Source plasma (SP) is the primary starting material for 87% of plasma‐derived medicinal products globally. Plasmavigilance is a program designed to collect, analyze, and monitor donor adverse events (AEs) across the SP collection industry. Donor retention depends on donors having a safe and satisfactory experience. This study analyzes AE rates and SP donor characteristics that may be predictors of an AE.
Study Design and Methods
Donation data for 1.1 million donors making 12,183,182 SP donations over a 4‐month period were analyzed. This represented approximately 72% of the donations collected by the U.S. plasma industry. The Standard for Recording Donor Adverse Events was used for AE definitions and classifications.
Results
The overall AE rate was 15.85/104 donations. The two AEs with the highest rates were Hypotensive and Phlebotomy events (8.32 and 5.91/104 donations, respectively). Females had higher overall AE rates than males (25.76 vs. 9.85/104 donations), and first‐time donors had higher overall AE rates than repeat donors (136.66 vs. 12.37/104 donations). Weight, body mass index, age, and pre‐donation estimated blood volume also were predictors of AE.
Discussion
SP donors have low AE rates with 90% being events classified as Hypotensive or Phlebotomy. Special attention and mitigation strategies should be directed to donors who are young, lightweight (between 100 and 124 pounds), female, or first‐time donors to further reduce the incidence of AE, continue to ensure the donor has a safe experience, and facilitate donor retention.
See editorial on page 2803–2805, in this issue</abstract><cop>Hoboken, USA</cop><pub>John Wiley & Sons, Inc</pub><pmid>34390267</pmid><doi>10.1111/trf.16612</doi><tpages>17</tpages><orcidid>https://orcid.org/0000-0003-1602-5248</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0041-1132 |
| ispartof | Transfusion (Philadelphia, Pa.), 2021-10, Vol.61 (10), p.2941-2957 |
| issn | 0041-1132 1537-2995 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9291118 |
| source | Wiley Online Library Journals Frontfile Complete |
| subjects | adverse events Blood Donors and Blood Collection Blood volume Body mass Body mass index Body size donation frequency Phlebotomy Plasma plasmavigilance Retention source plasma |
| title | Plasmavigilance—Adverse events among US Source plasma donors |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T10%3A25%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Plasmavigilance%E2%80%94Adverse%20events%20among%20US%20Source%20plasma%20donors&rft.jtitle=Transfusion%20(Philadelphia,%20Pa.)&rft.au=Schreiber,%20George%20B.&rft.date=2021-10&rft.volume=61&rft.issue=10&rft.spage=2941&rft.epage=2957&rft.pages=2941-2957&rft.issn=0041-1132&rft.eissn=1537-2995&rft_id=info:doi/10.1111/trf.16612&rft_dat=%3Cproquest_pubme%3E2578689000%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2578689000&rft_id=info:pmid/34390267&rfr_iscdi=true |